MedPath

Dalpiciclib

Generic Name
Dalpiciclib
Drug Type
Small Molecule
Chemical Formula
C25H30N6O2
CAS Number
1637781-04-4
Unique Ingredient Identifier
5ZHA5P4PFX

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/12/02
Not Applicable
Not yet recruiting
Fujian Medical University
2024/11/12
Phase 2
Recruiting
Peking University
2024/10/21
Phase 2
Not yet recruiting
Peking University
2024/09/25
Phase 4
Not yet recruiting
2024/09/25
Phase 3
Active, not recruiting
Zhimin Shao
2024/09/20
Not Applicable
Not yet recruiting
Liu Shu
2024/08/16
Phase 2
Not yet recruiting
Beijing 302 Hospital
2024/08/14
Phase 2
Not yet recruiting
2024/04/02
Phase 2
Recruiting
2024/03/08
N/A
Not yet recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Dalpiciclib Isethionate Tablets
国药准字H20210055
化学药品
片剂
12/31/2021
Dalpiciclib Isethionate Tablets
国药准字H20210056
化学药品
片剂
12/31/2021
Dalpiciclib Isethionate Tablets
国药准字H20210054
化学药品
片剂
12/31/2021

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath